0001415889-23-003679.txt : 20230301 0001415889-23-003679.hdr.sgml : 20230301 20230301164109 ACCESSION NUMBER: 0001415889-23-003679 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontes Josias CENTRAL INDEX KEY: 0001868415 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39746 FILM NUMBER: 23694311 MAIL ADDRESS: STREET 1: C/O SIGILON THERAPEUTICS, INC. STREET 2: 100 BINNEY STREET, SUITE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc. CENTRAL INDEX KEY: 0001821323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474005543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-336-7540 MAIL ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-03012023_090358.xml X0306 4 2023-02-28 0001821323 Sigilon Therapeutics, Inc. SGTX 0001868415 Pontes Josias C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 false true false false CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 1.09 2023-02-28 4 A 0 140000 0 A 2033-02-27 Common Stock 140000 140000 D The options vest as to 25% of the underlying shares of common stock on February 28, 2024, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the options are fully vested. /s/ Matthew Kowalsky, Attorney-in-Fact 2023-03-01